110 related articles for article (PubMed ID: 21504709)
21. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
22. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
24. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
[TBL] [Abstract][Full Text] [Related]
25. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
26. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
[TBL] [Abstract][Full Text] [Related]
27. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N
Yang L; Chen Y; Liu N; Shi Q; Han X; Gan W; Li D
J Hematol Oncol; 2021 Mar; 14(1):46. PubMed ID: 33741027
[TBL] [Abstract][Full Text] [Related]
28. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
[TBL] [Abstract][Full Text] [Related]
29. A unique case of renal carcinoma with Xp11.2 translocations/ TFE3 gene fusions in a 3-year-old child, with coexistent von Hippel-Lindau gene mutation.
Parast MM; Eudy G; Gow KW; Amin M; Shehata B
Pediatr Dev Pathol; 2004; 7(4):403-6. PubMed ID: 15383938
[TBL] [Abstract][Full Text] [Related]
30. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.
He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R
Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997
[TBL] [Abstract][Full Text] [Related]
32. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
[TBL] [Abstract][Full Text] [Related]
33. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.
Zhu QQ; Wang ZQ; Zhu WR; Chen WX; Wu JT
Acta Radiol; 2013 Apr; 54(3):355-62. PubMed ID: 23446748
[TBL] [Abstract][Full Text] [Related]
34. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.
Sukov WR; Hodge JC; Lohse CM; Leibovich BC; Thompson RH; Pearce KE; Wiktor AE; Cheville JC
Am J Surg Pathol; 2012 May; 36(5):663-70. PubMed ID: 22498819
[TBL] [Abstract][Full Text] [Related]
35. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
36. Translocation Renal Cell Carcinoma in a Child Previously Treated for Infantile Fibrosarcoma.
Ma J; Pan C; Yin M
Pediatr Dev Pathol; 2018; 21(4):418-422. PubMed ID: 28478739
[TBL] [Abstract][Full Text] [Related]
37. MiT family translocation renal cell carcinoma.
Argani P
Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.
Kato H; Kanematsu M; Yokoi S; Miwa K; Horie K; Deguchi T; Hirose Y
J Magn Reson Imaging; 2011 Jan; 33(1):217-20. PubMed ID: 21182142
[TBL] [Abstract][Full Text] [Related]
39. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
[TBL] [Abstract][Full Text] [Related]
40. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.
Onder AM; Teomete U; Argani P; Toledano S; Zilleruelo G; Rodriguez MM
Pediatr Nephrol; 2006 Oct; 21(10):1471-5. PubMed ID: 16807766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
